These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8027560)

  • 21. Dilazep and dipyridamole inhibit tissue factor expression on monocytes induced by IgG from patients with antiphospholipid syndrome.
    Zhou H
    Acta Pharmacol Sin; 2004 Oct; 25(10):1366-71. PubMed ID: 15456541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD40 engagement on endothelial cells promotes tissue factor-dependent procoagulant activity.
    Zhou L; Stordeur P; de Lavareille A; Thielemans K; Capel P; Goldman M; Pradier O
    Thromb Haemost; 1998 May; 79(5):1025-8. PubMed ID: 9609241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of human monoclonal anticardiolipin antibodies on platelet function and on tissue factor expression on monocytes.
    Reverter JC; Tàssies D; Font J; Khamashta MA; Ichikawa K; Cervera R; Escolar G; Hughes GR; Ingelmo M; Ordinas A
    Arthritis Rheum; 1998 Aug; 41(8):1420-7. PubMed ID: 9704640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids.
    Takeya H; Mori T; Gabazza EC; Kuroda K; Deguchi H; Matsuura E; Ichikawa K; Koike T; Suzuki K
    J Clin Invest; 1997 May; 99(9):2260-8. PubMed ID: 9151800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to beta2-glycoprotein I associated with antiphospholipid syndrome suppress the inhibitory activity of tissue factor pathway inhibitor.
    Salemink I; Blezer R; Willems GM; Galli M; Bevers E; Lindhout T
    Thromb Haemost; 2000 Oct; 84(4):653-6. PubMed ID: 11057865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
    Adams M
    Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome.
    Dobado-Berrios PM; López-Pedrera C; Velasco F; Aguirre MA; Torres A; Cuadrado MJ
    Thromb Haemost; 1999 Dec; 82(6):1578-82. PubMed ID: 10613637
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monocyte IL-10 produced in response to lipopolysaccharide modulates thrombin generation by inhibiting tissue factor expression and release of active tissue factor-bound microparticles.
    Poitevin S; Cochery-Nouvellon E; Dupont A; Nguyen P
    Thromb Haemost; 2007 Apr; 97(4):598-607. PubMed ID: 17393023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of tissue factor procoagulant activity in myelomonocytic cells inoculated by the agent of human granulocytic ehrlichiosis.
    Behl R; Klein MB; Dandelet L; Bach RR; Goodman JL; Key NS
    Thromb Haemost; 2000 Jan; 83(1):114-8. PubMed ID: 10669164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
    Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
    J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of autoantibody-induced monocyte tissue factor expression.
    Wolberg AS; Roubey RA
    Thromb Res; 2004; 114(5-6):391-6. PubMed ID: 15507269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3.
    Fishman P; Falach-Vaknine E; Zigelman R; Bakimer R; Sredni B; Djaldetti M; Shoenfeld Y
    J Clin Invest; 1993 Apr; 91(4):1834-7. PubMed ID: 8473523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue factor encryption.
    Bach RR
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):456-61. PubMed ID: 16397140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies.
    Zhu M; Olee T; Le DT; Roubey RA; Hahn BH; Woods VL; Chen PP
    Br J Haematol; 1999 Apr; 105(1):102-9. PubMed ID: 10233371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II induces the expression of tissue factor and its mechanism in human monocytes.
    He M; He X; Xie Q; Chen F; He S
    Thromb Res; 2006; 117(5):579-90. PubMed ID: 15953627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of cardiolipin oxidation on solid-phase immunoassay for antiphospholipid antibodies.
    Schlame M; Haller I; Sammaritano LR; Blanck TJ
    Thromb Haemost; 2001 Dec; 86(6):1475-82. PubMed ID: 11776316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A method of analyzing procoagulant activity in monocytes at single cell level.
    Recalde H; Miranda GR
    Haematologica; 2003 Jan; 88(1):44-53. PubMed ID: 12551826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of somatostatin on circulating tissue factor procoagulant activity and protein.
    Boden G; Vaidyula V; Homko C; Mozzoli M; Rao AK
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1333-9. PubMed ID: 17213471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staphylococcal peptidoglycan initiates an inflammatory response and procoagulant activity in human vascular endothelial cells: a comparison with highly purified lipoteichoic acid and TSST-1.
    Mattsson E; Heying R; van de Gevel JS; Hartung T; Beekhuizen H
    FEMS Immunol Med Microbiol; 2008 Jan; 52(1):110-7. PubMed ID: 18031538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.